1-6 of 6
Yiyu Zou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Smoking-Associated Carcinogen–Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation

Available to Purchase
Ritesh K. Aggarwal, Simone Sidoli, Jingli Wang, Srabani Sahu, Rahul Sanawar, Varun Gupta, Srinivas Aluri, Vineeth Sukrithan, Charan T.R. Vegivinti, Phaedon D. Zavras, Divij Verma, Shanisha Gordon-Mitchell, Beamon Agarwal, Tanya Verma, Daniel T. Starczynowski, Ulrich G. Steidl, Aditi Shastri, Balazs Halmos, Lindsay M. LaFave, Haiying Cheng, Amit Verma, Yiyu Zou
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (4): 746–755.
https://doi.org/10.1158/1078-0432.CCR-24-2182
Published: 17 February 2025
View articletitled, Smoking-Associated Carcinogen–Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation
Open the PDF for Smoking-Associated Carcinogen–Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation in another window
Includes: Supplementary data
Journal Articles

PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma

Free
Elaine Y. Chung, Yun Mai, Urvi A. Shah, Yongqiang Wei, Elise Ishida, Keisuke Kataoka, Xiaoxin Ren, Kith Pradhan, Boris Bartholdy, Xiaolei Wei, Yiyu Zou, Jinghang Zhang, Seishi Ogawa, Ulrich Steidl, Xingxing Zang, Amit Verma, Murali Janakiram, B. Hilda Ye
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (12): 3589–3601.
https://doi.org/10.1158/1078-0432.CCR-18-3033
Published: 14 June 2019
View articletitled, PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
Open the PDF for PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma in another window
Includes: Supplementary data
Journal Articles

The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab

Free
Roman Perez-Soler, Yiyu Zou, Tianhong Li, Yi He Ling
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6766–6777.
https://doi.org/10.1158/1078-0432.CCR-11-0545
Published: 31 October 2011
View articletitled, The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab
Open the PDF for The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab in another window
Includes: Supplementary data
Journal Articles

PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase

Free
Yi-He Ling, Miguel Aracil, Yiyu Zou, Ziqiang Yuan, Bo Lu, José Jimeno, Ana Maria Cuervo, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5353–5366.
https://doi.org/10.1158/1078-0432.CCR-10-1948
Published: 14 August 2011
View articletitled, PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase
Open the PDF for PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase in another window
Journal Articles

p53 Aerosol Formulation with Low Toxicity and High Efficiency for Early Lung Cancer Treatment

Free
Yiyu Zou, Carmen Tornos, Xuan Qiu, Marie Lia, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4900–4908.
https://doi.org/10.1158/1078-0432.CCR-07-0395
Published: 15 August 2007
View articletitled, p53 Aerosol Formulation with Low Toxicity and High Efficiency for Early Lung Cancer Treatment
Open the PDF for p53 Aerosol Formulation with Low Toxicity and High Efficiency for Early Lung Cancer Treatment in another window
Journal Articles

Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models

Free
Yiyu Zou, Hao Fu, Sukhen Ghosh, David Farquhar, Jim Klostergaard
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (21): 7382–7391.
https://doi.org/10.1158/1078-0432.CCR-04-0334
Published: 08 November 2004
View articletitled, Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models
Open the PDF for Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models in another window